Advertisement

European Journal of Clinical Pharmacology

, Volume 64, Issue 5, pp 553–554 | Cite as

Detection of the pharmaceutical agent glaucine as a recreational drug

  • Paul I. Dargan
  • Jenny Button
  • Leonard Hawkins
  • John R. H. Archer
  • Hanna Ovaska
  • Satnam Lidder
  • John Ramsey
  • David W. Holt
  • David M. Wood
Letter to the Editors

Keywords

Glaucine Recreational drugs Drug legislation Toxicological screening 

References

  1. 1.
    Rovinskia VI (1989) A case of hallucinogen-like action of glaucine. Klin Med (Mosk) 67:107–108Google Scholar
  2. 2.
    Rovinskia VI (2006) Acute glaucine syndrome in the physician’s practice: the clinical picture and potential danger. Klin Med (Mosk) 84:68–70Google Scholar
  3. 3.
    Asencio M, Hurtado-Guzmán C, López JJ et al (2005) Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity. Bioorg Med Chem 13:3699–3704PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Paul I. Dargan
    • 1
  • Jenny Button
    • 2
  • Leonard Hawkins
    • 1
  • John R. H. Archer
    • 3
  • Hanna Ovaska
    • 1
  • Satnam Lidder
    • 1
  • John Ramsey
    • 4
  • David W. Holt
    • 2
  • David M. Wood
    • 1
  1. 1.Guy’s and St Thomas’ NHS Foundation TrustGuy’s and St Thomas’ Poisons UnitLondonUK
  2. 2.Analytical Unit, St. George’s University of LondonLondonUK
  3. 3.General Medicine and Clinical PharmacologySt George’s University of LondonLondonUK
  4. 4.TICTAC Communications Ltd, St. George’s University of LondonLondonUK

Personalised recommendations